BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues
BreezeBio has raised $60.0M in total funding. The most recent round was Series B. The last funding was announced in February 2026.
BreezeBio is headquartered in South San Francisco, United States.
BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues
BreezeBio is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BreezeBio — Funding & Investors." VCBacked, February 25, 2026, https://www.vcbacked.co/company/breezebio. Accessed July 18, 2026.
VCBacked. (2026). BreezeBio — Funding & Investors. Retrieved July 18, 2026, from https://www.vcbacked.co/company/breezebio
{{cite web |title=BreezeBio — Funding & Investors |url=https://www.vcbacked.co/company/breezebio |website=VCBacked |access-date=July 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated